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The compound, 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), is highly toxic. The LD50
for male and female rats given a single oral
dose is 23 and 45 jug/kg, respectively (1).
Adverse effects have been observed in a
teratology study in which pregnant rats were
given oral doses of 0.125-2.0 jug/kg-day
TCDD from day 6 through day 15 of gestation
(2). The adverse effects were increased fetal
mortality, early and late resorptions and
intestinal hemorrhage in the fetuses. No ad-
verse effects were noted at the 0.03 ptg/kg-
day level.
In humans and rabbits, contamination of
the skin with TCDD produces chloracne-
like lesions (3, 4). This disease is character-
ized by the appearance of hyperkeratosis,
papules, comedones and cysts.
There is no available information on the
absorption, excretion or tissue distribution
of TCDD in animals. Therefore, this study
was done to determine the excretion and
tissue distribution of radioactivity derived
from TCDD-14C following a single oral dose
of the labeled compound.
*Oakdale Toxicology Center, Department of Phar-
macology, University of Iowa, Iowa City, Iowa
52240.
tToxicology Unit, Chemical Biology Research, The
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Methods
Animals
Male Spartan strain Sprague-Dawley rats
weighing 165-210 g were used. The rats
were acclimated to the environment of the
metabolism cages 5 days prior to dosage.
Food and water were provided ad libitum
throughout the experiment.
14C-Tetrachlorodibenzo-pdioxin
Uniformly labeled TCDD-_4C was synthe-
sized at the Radiochemistry Research Lab-
oratory of The Dow Chemical Company.
The specific activity was 2.8 PACi/mg. Mass
spectrometric and gas-liquid chromatogra-
phic analyses of the TCDD14C sample indi-
cated a purity of 93.3 and 95.0%SO, respec-
tively.
Dosage
TCDD was dissolved in acetone. Subse-
quently, one part of the acetone solution
was added to and mixed with nine parts of
USP corn oil. The acetone-corn oil solu-
tion of TCDD was given to rats in 5 ml/kg
amounts by intubation. This volume of the
solution provided a dose of 50 /Lg/kg and 0.14
,uCi/kg TCDD-14C.
Sample Collection
After administering the solution contain-
ing TCDD-14C, the rats were placed in all-
September 1973 241glass Roth metabolism chambers which
were equipped for separate collection of
urine, feces, and expired air. The CO2 in
the exiting air stream was trapped by bub-
bling it through a 3:7 ethanolamine-2-
methoxyethanol mixture.
Radioactivity Analysis
Samples of urine, feces, and tissues were
oxidized to 14CO2 by combustion and analyzed
for radioactivity (5). By using this method,
the recovery of radioactivity from samples
spiked with 14C was 95 ± 5%o. To determine
the radioactivity expired as CO2, 5-ml ali-
quots of the solution used to trap the CO2
were added to 15 ml of a scintillation count-
ing solution containing 4 g 2,5-diphenyl-
oxazole (PPO) and 0.1 g 1,4-bis-2-(5-phenyl-
oxazolyl) benzene (POPOP) per liter of 1:1
toluene-2-methoxyethanol. Samples were
counted for radioactivity in a Nuclear Chi-
cago Mark II liquid scintillation counter, and
quench corrections were made by use of
the internal standard technique.
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Results
The percentage of the total dose of radi-
oactivity excreted daily in the feces, urine,
or expired air over a 21-day period follow-
ing a single oral dose of TCDD-14C is shown
in Figure 1. Approximately 30%So of the
14C activity was excreted in the feces dur-
ing the first 48 hr. Most of this probably
represents unabsorbed TCDD-14C. Over the
remaining 19 days, 1-2%o per day of the
14C activity was excreted in the feces. A
total of 53.2 ± 3.8%o of the administered
dose was excreted via the feces over the
21-day period. The total cumulative amount
excreted in the urine and expired air was
13.2 ± 1.3%o and 3.2 ± 0.1%o, respectively.
To determine the overall rate of clear-
ance of 14C administered as TCDD from the
body, the total cumulative amount of 14C
excreted in feces, urine, and expired air at
the end of each day was subtracted from
the total dose administered to the ani-
mal. These values, representing the percen-
tage of the total dose remaining in the ani-
mal at the end of each day, were then plotted
FIGURE 1. Excretion of 14C activity by rats following
a single oral dose of 50 ,ug/kg (0.14 ,uCi/kg) 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Each point represents
the mean ± SE for three rats.
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FIGURE 2. Clearance of 14C activity from the body
of rats given a single oral dose of 50 ug/kg (0.14
,uCi/kg) 2,3,7,8-tetrachlorodibenzo-p-dioxin. Each
value represents the mean ± SE for three rats.
semilogarithmically as a function of time
(Fig. 2). Except for the first 2 days fol-
lowing administration, the clearance of 14C
activity from the body followed apparent
first-order rate kinetics. The half-life for
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924clearance, t%, was 17.4 ± 5.6 days. As pre-
viously indicated, it was assumed that the
relatively large amount excreted during the
first 2 days had not been absorbed. There-
fore, these values were not used in calculat-
ingthe clearance rate.
Analyses of tissues indicated that the 14C
activity derived from TCDD and/or its
breakdown products was located chiefly in
the liver and fat (Table 1). The percentage
of the dose per gram of liver 3, 7, and 21
days following administration was 3.18,
4.49 and 1.337o/g, respectively. Comparable
values for fat were 2.60, 3.22, and 0.43%o/g.
Smaller concentrations of 14C activity
were found in other tissues: muscle, testes,
lungs, heart, skin, spleen, stomach, pancreas,
brain, bone, kidneys, and adrenals (Table
2). Standard errors as large as the mean
suggest that some of the values presented
in Table 2 may be a result of experimental
error: adrenals, 3 days; bone, 7 days; spleen,
21 days; pancreas, 21 days. Radioactivity ex-
ceeding background in these tissues at the
indicated time was detected in only one of
three rats.
The value given in Table 2 for adrenals
21 days following administration suggests
that this tissue may concentrate TCDD-'14C
and/or a metabolite. This observation is
very likely due to experimental error. The
disintegrations per minute (dpm) above
background for this tissue were only 17, 29,
and 90. Since the total amount of tissue avail-
able for analysis was less than 20 mg, the
multiplication factor may have magnified
the error manyfold.
Total recovery of the administered 14C
activity was determined for those rats used
in the 21-day experiment. The 14C activity
remaining in the unused carcass was de-
termined by analyzing an aliquot of a homo-
genate of the remaining carcass. The recov-
ery was 96.8 ± 3.0%o.
Discussion
In the study reported herein, the tissue
distribution and excretion of 14C activity
have been evaluated in rats following a single
oral dose of TCDD-14C. Almost 30%o of the
Table 1. 14C activity expressed as percentage of dose
per gram in the liver and fat of rats 3, 7, and 21 days
following a single oral dose of TCDD-14C."
Activity, %o/gb
Tissue 3 days 7 days 21 days
Liver 3.18±0.21 4.49±0.62 1.33±0.70
(47%)C (45%)C (11%)C
Fat 2.60±0.48 3.22±0.63 0.43 d
a Dose: 50 1sg/kg (0.14 ,uCi/kg); 3 rats/observa-
tion.
b Mean ± standard error.
Percentage of the total dose found in the entire
liver.
d Mean for 2 rats.
Table 2. 11C activity expressed as percentage of dose
per gram in various tissues of rats 3, 7, and 21 days
following a single oral dose of TCDD-14C."
Activity, %o/g b
Tissue
Muscle
Testes
Lungs
Heart
Skin
Spleen
Stomach
Pancreas
Brain
Bone
Kidneys
Adrenals
3 days
0.38± 0.01
0.38±0.03
0.27±0.02
0.20±0.03
0.19 ±0.10
0.15±0.02
0.16±0.05
0.11±0.06
0.06±0.00
0.09±0.03
0.00 d
0.79±0.79
7 days
0.21±0.05
0.36±0.10
0.39±0.14
0.40±0.16
0.19±0.10
0.95±0.53
0.10±0.00
0.16 e
0.13±0.09
0.42±0.42
0.34±0.17
0.02±0.02
21 days
0.20±0.12
0.11±0.09
0.06±0.05
0.09±0.05
0.09±0.04
0.22±0.22
0.02±0.02
0.16±0.16
0.01±0.01
0.08±0.08
0.00 d
3.69±1.77 e
a Dose: 50 /g/kg (0.14 ,tCi/kg); 3 rats/observa-
tion.
b Mean ± standard error.
e Mean of 2 rats.
d No activity above background in all 3 rats.
e This large value may be an experimental error.
The activity above background for the adrenals
of the three rats was 17, 29, and 90 dpm. Since
the total amount of tissue was less than 20 mg,
the multiplication factor may have magnified
the error manyfold.
dose administered was eliminated via the
feces during the first 48 hr following treat-
ment. The excretion of 14C activity via the
feces after the first 48 hr ranged from 1 to
2%o/day. It appears that TCDD is incom-
pletely absorbed from the gastrointestinal
tract. The 14C activity derived from the ab-
September 1973 243sorbed TCDD-14C also is excreted mainly
via the feces.
Once absorbed in the body, most of the
14C activity derived from TCDD-14C is local-
ized in the liver and fat. The data suggest
that the level in these tissues is approxi-
mately 10-fold that in other tissues. The
14C level in liver and fat seemed to increase
between 3 and 7 days following administra-
tion; however, the 14C activity in liver and
fat decreased more between 7 and 21 days
than would have been predicted on assum-
ing that the rate of clearance from these
tissues would be equal to the rate of clear-
ance from the body. Between days 7 and
21, the 14C level in muscle remained essen-
tially unchanged. Therefore, redistribution
of TCDD or metabolites of TCDD may have
been occurring. The apparently high level
in the adrenals 21 days after administra-
tion results probably from experimental er-
ror.
The dose of TCDD given to the male rats
used in this study, 50 jug/kg, was approxi-
mately twice the LDs0 (23 uLg/kg). This
large dose was necessitated because of the
specific activity of the TCDD-14C used. Rats
lost weight, and their physical condition was
poor; this typifies the insidious response to
TCDD (1). Survival of the rats for 21 days
was not totally unexpected, because in pre-
vious studies on the lethality of TCDD deaths
frequently occurred 20 days or more follow-
ing a single oral dose of similar magnitude
(1). With doses that do not induce untoward
effects, the compound may be excreted at a
different rate.
The results do not differentiate between
14C activity derived from TCDD and that of
possible metabolites. However, small amounts
of 14C activity were detected in the expired
air and urine within the first 10 days follow-
ing administration. This is evidence that
some metabolic alteration or breakdown of
TCDD occurs.
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